SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001821825-21-000005
Filing Date
2021-06-21
Accepted
2021-06-21 08:16:50
Documents
81
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ogn-20210331.htm   iXBRL 10-Q 1460663
2 EX-31.1 ogn3312021ex311.htm EX-31.1 7686
3 EX-31.2 ogn3312021ex312.htm EX-31.2 7808
4 EX-32.1 ogn3312021ex321.htm EX-32.1 3778
5 EX-32.2 ogn3312021ex322.htm EX-32.2 3475
  Complete submission text file 0001821825-21-000005.txt   7711204

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ogn-20210331.xsd EX-101.SCH 55880
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ogn-20210331_cal.xml EX-101.CAL 92066
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ogn-20210331_def.xml EX-101.DEF 258553
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ogn-20210331_lab.xml EX-101.LAB 573106
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ogn-20210331_pre.xml EX-101.PRE 403138
11 EXTRACTED XBRL INSTANCE DOCUMENT ogn-20210331_htm.xml XML 1511876
Mailing Address 30 HUDSON STREET FL 33 JERSEY CITY NJ 07302
Business Address 30 HUDSON STREET FL 33 JERSEY CITY NJ 07302 551-430-6000
Organon & Co. (Filer) CIK: 0001821825 (see all company filings)

IRS No.: 464838035 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40235 | Film No.: 211027512
SIC: 2834 Pharmaceutical Preparations